Advertisement

Topics

HeartSine Technologies, Ltd. Company Profile

23:35 EST 24th February 2017 | BioPortfolio


News Articles [431 Associated News Articles listed on BioPortfolio]

Sterilization Technologies Market Expected to Reach $8,578 Million by 2022, Globally - Allied ...

     (Logo: http://photos.prnewswire.com/prnh/20140911/647229) Summary of the ReportSterilization Technologies Marketcan be accessed on the website at: https://www.alliedmarketresearch.com/...

DBV Technologies: DBV Technologies Reports December 31, 2016 Cash Position

Press Release Montrouge, France, February 20, 2017 DBV Technologies Reports December 31, 2016 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today...

United Technologies Moves Higher On Credit Suisse Upgrade

HARTFORD (dpa-AFX) - Industrial conglomerate United Technologies (UTX) is posting a notable gain in afternoon trading on Monday. Shares of United Technologies are currently up by 1.8 percent, on p...

Greengro Technologies, Unveils Advantageous 'GreenGro 3-Tier Franchise Model'

ANAHEIM, CA--(Marketwired - Sep 23, 2016) - Greengro Technologies, Inc.( OTC PINK : GRNH), a world-class provider of eco-friendly green technologies, has announced Read more...

How do we regulate advanced technologies along social or ethical lines?

(Arizona State University) Society faces several new and powerful technologies that could alter the human trajectory into the future and, the public wants clear guidelines as to how these technologies...

DBV Technologies: DBV Technologies Reports September 30, 2016 Cash Position

Press ReleaseMontrouge, France, November 3, 2016 DBV Technologies Reports September 30, 2016 Cash Position DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today...

Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond

SOURCE December 12, 2016 Abstract New health technologies are rapidly emerging from various areas of bioscience research, such as gene editing, regenerative medicine and synthetic biology. These techn...

Specific Technologies announces new results and a major new NIAID grant award

(Specific Technologies) Specific Technologies today announces development of a new paradigm for the quantitative determination of antibiotic efficacy.

Drugs and Medications [0 Results]

None

PubMed Articles [393 Associated PubMed Articles listed on BioPortfolio]

Changing Memories: Between Ethics and Speculation.

Over the past decade, a debate has emerged between those who believe that memory-modulating technologies are inherently dangerous and need to be regulated and those who believe these technologies pres...

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Review of chemical and electrokinetic remediation of PCBs contaminated soils and sediments.

Polychlorinated biphenyls (PCBs) are manmade organic compounds, and pollution due to PCBs has been a global environmental problem because of their persistence, long-range atmospheric transport and bio...

Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond.

New health technologies are rapidly emerging from various areas of bioscience research, such as gene editing, regenerative medicine and synthetic biology. These technologies raise promising medical po...

Mobile Virtual Learning Object for the Assessment of Acute Pain as a Learning Tool to Assess Acute Pain in Nursing: An Analysis of the Mental Workload.

The inclusion of new technologies in education has motivated the development of studies on mental workload. These technologies are now being used in the teaching and learning process. The analysis ena...

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Application-based Perioperative Management of the Radical Cystectomy Patient

The purpose of this study is to learn whether it is feasible to use the LifeScience Technologies application (LST app) in patients undergoing radical cystectomy with the eventual goal to r...

Influence of Indoor Air Filtration Strategies on Occupant Health Indicators

The purpose of this study is to evaluate whether two different central air purification technologies reduce air pollutant exposure and beneficially influence health as evaluated with a sui...

An Innovative Occupational Program Using New Technologies (KODRO) Life of Nursing

Randomized controlled trial for assessing the effects resulting from an innovative occupational program using new technologies (KODRO) on nursing home residents' quality of life Con...

Novel Methods for Ascertainment of Gout Flares -A Pilot Study

The purpose of this study is to determine the feasibility and acceptability of using different remote data collection technologies to ascertain flare occurrence among gout patients. Two te...

Companies [1190 Associated Companies listed on BioPortfolio]

HeartSine Technologies, Inc.

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the developm...

HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the developm...

HeartSine Technologies, Ltd.

HeartSine™ Technologies, Inc.

As a world leader in personal and public access cardiac rhythm management, our mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the de...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "HeartSine Technologies, Ltd." on BioPortfolio

We have published hundreds of HeartSine Technologies, Ltd. news stories on BioPortfolio along with dozens of HeartSine Technologies, Ltd. Clinical Trials and PubMed Articles about HeartSine Technologies, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HeartSine Technologies, Ltd. Companies in our database. You can also find out about relevant HeartSine Technologies, Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record